SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Keryx Biopharmaceuticals Announces Filing of New Drug Application for Marketing Approval of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco Inc.